| Dr Ernesto G Gonzalez, MD | |
|
759 Chestnut St # Wg820, Springfield, MA 01107-1619 | |
| (413) 794-5307 | |
| (413) 794-8430 |
| Full Name | Dr Ernesto G Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 759 Chestnut St # Wg820, Springfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215321765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 278254 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baystate Medical Practices Inc | 5991602971 | 1015 |
| Reliant Medical Group Inc | 5597755322 | 543 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
| Entity Name | Signature Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508804949 PECOS PAC ID: 7719876267 Enrollment ID: O20040312000372 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
| Entity Name | Reliant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ernesto G Gonzalez, MD 280 Chestnut Street, 2nd Floor, Springfield, MA 01199-1001 Ph: (413) 794-5700 | Dr Ernesto G Gonzalez, MD 759 Chestnut St # Wg820, Springfield, MA 01107-1619 Ph: (413) 794-5307 |
News Archive
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease — where conventional heart therapies and symptom management strategies are no longer effective.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.
Extending Medicaid coverage to currently uninsured adults is likely to increase the cost of the program, according to health policy researchers, because those patients are prone to have more expensive health problems than nondisabled adults currently enrolled in Medicaid.
› Verified 5 days ago
Ravneet Kaur Thind, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 759 Chestnut St, Springfield, MA 01199 Phone: 413-794-0000 | |
Fadi A Bsat, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Springfield, MA 01107 Phone: 413-794-9939 | |
Debra A. Disandro, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3550 Main St Ste 302, Springfield, MA 01107 Phone: 413-781-8290 Fax: 413-737-8540 | |
Dr. Darlene Vargas Maldonado, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3455 Main St Ste C, Springfield, MA 01107 Phone: 413-794-8484 | |
Danielle Nicole Finch, D.O., MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Baystate Medical Ctr, 759 Chestnut St, Springfield, MA 01199 Phone: 413-794-0000 | |
Jean R. Talati, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 305 Bicentennial Hwy, Springfield, MA 01118 Phone: 413-733-4101 Fax: 413-796-6821 | |
Dr. David R. Kattan, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 Main St, 4th Fl, Ste D, Springfield, MA 01107 Phone: 413-794-7045 Fax: 413-794-7345 |